Praxis Precision Medicines (PRAX) Non-Current Deffered Revenue (2022 - 2024)

Praxis Precision Medicines' Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $293000.0 for Q3 2024.

• In Q3 2024, Non-Current Deffered Revenue fell 80.67% year-over-year to $293000.0; the TTM figure through Sep 2024 stood at $293000.0 (down 80.67% YoY), while the FY2023 annual figure was $1.2 million, down 46.79% from the prior year.
• Non-Current Deffered Revenue was $293000.0 for Q3 2024 at Praxis Precision Medicines, down from $588000.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $2.2 million in Q4 2022 to a low of $293000.0 in Q3 2024.
• Historically, Non-Current Deffered Revenue has averaged $1.2 million across 3 years, with a median of $1.3 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue tumbled 46.79% in 2023, then tumbled 80.67% in 2024.
• A 3-year view of Non-Current Deffered Revenue shows it stood at $2.2 million in 2022, then tumbled by 46.79% to $1.2 million in 2023, then plunged by 74.76% to $293000.0 in 2024.
• The last three Non-Current Deffered Revenue figures came in at $293000.0 (Q3 2024), $588000.0 (Q2 2024), and $866000.0 (Q1 2024), per Business Quant data.